...
首页> 外文期刊>African Journal of Biotechnology >Acute and sub-chronic oral toxicity studies of the extracts from herbs in Phikud Navakot
【24h】

Acute and sub-chronic oral toxicity studies of the extracts from herbs in Phikud Navakot

机译:Phikud Navakot中草药提取物的急性和亚慢性口服毒性研究

获取原文
           

摘要

This study presents data from oral acute and sub-chronic (90-day) toxicity effect of the extracts from herbs in Phikud Navakot (PN) which is commonly used in Thai traditional medicine for alleviation of the clinical sign of hyperlipidemia, cardiovascular diseases, and cerebrovascular diseases. The single and repeated dose of the extracts were administered to Sprague Dawley rats as described in the OECD code 420 guideline for acute test and OECD code 408 guideline for sub-chronic test respectively. The variables included were body weights; feed consumption, organ weights, hematology and blood clinical chemistry, and histopathology were performed. Acute toxicity test revealed that, the limit dose of 2,000 mg/kg did not cause any mortality or symptoms of toxicity in all rats during the observation period. In the sub-chronic tests, the results did not show any treatment–related effect of toxicity.?Therefore, our obtained results suggest that PN is a relatively nontoxic herb for single and repeated oral administration. However, the contraindication?of the usage of PN is related to the high levels of uric acid during and after a high dose oral administration.
机译:这项研究提供了来自Phikud Navakot(PN)中草药提取物的口服急性和亚慢性(90天)毒性作用的数据,Phikud Navakot(PN)通常在泰国传统医学中用于缓解高脂血症,心血管疾病和脑血管疾病。按照经合组织代码420急性试验指南和经合组织代码408亚慢性试验指南分别向Sprague Dawley大鼠给药单剂量和重复剂量的提取物。所包括的变量是体重。进行饲料消耗,器官重量,血液学和血液临床化学以及组织病理学检查。急性毒性试验表明,在观察期内,极限剂量2,000 mg / kg不会对所有大鼠造成任何死亡或毒性症状。在亚慢性试验中,结果未显示任何与治疗有关的毒性作用。因此,我们获得的结果表明,PN是单次和重复口服给药的相对无毒的草药。但是,PN的禁忌症与大剂量口服给药期间和之后尿酸水平高有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号